U.S. court rejects Teva's patent-infringement claims on Copaxone

Jan 30 (Reuters) - Teva Pharmaceutical Industries Ltd said on Monday a U.S. court rejected four of the Israel-based drugmaker's claims of patent infringement on its top-selling multiple sclerosis treatment.

http://finance.yahoo.com/news/u-court-rejects-tevas-patent-004616001.html